| |||||||||||||||||||||||||||||||||||
# of Animals | Phenotype | Strain | Sex | Value | Units | Conditions | Record ID | Condition 1 | Condition 2 | ||||||||||||||||||||||||||
3 | percentage of study population developing peritoneal carcinomatosis during a period of time | BDIX/OrlCrl | male | 0 | % | phosphate buffered saline (0.2 ml) then phosphate buffered saline (0.1 ml) | 111027 | phosphate buffered saline (0.2 ml) | phosphate buffered saline (0.1 ml) |